Anti-Müllerian hormone is a protein produced by the reproductive system that serves two very different purposes depending on when you encounter it. In a developing fetus, it drives one of the most consequential steps in sex differentiation. In adults, it has become one of the most widely used blood markers of ovarian reserve, the rough supply of eggs remaining in a woman’s ovaries. Despite its growing popularity in fertility clinics and direct-to-consumer tests, AMH is routinely misunderstood, and a low result does not mean what most people assume it does.
What AMH Does During Fetal Development
AMH was originally discovered for its role in the embryo. In a male fetus, immature cells in the developing testes begin producing AMH early in pregnancy. The hormone’s job is to cause the Müllerian ducts, a pair of embryonic structures that would otherwise develop into a uterus and fallopian tubes, to break down and disappear.1PubMed. Anti-müllerian hormone in early human development AMH binds to specific receptors on the surface of these ducts, triggering a chain of signals that leads to their degeneration.2PubMed. Anti-Müllerian hormone: A function beyond the Müllerian structures Without AMH, those ducts persist. That is literally how the hormone got its name: it acts against the Müllerian structures. The French endocrinologist Alfred Jost, working in the mid-twentieth century, proved that male sex differentiation requires both testosterone and this second testicular signal, which we now call AMH.3PubMed. Professor Alfred Jost: the builder of modern sex differentiation
In female fetuses, AMH is absent or barely detectable during this critical window, so the Müllerian ducts survive and go on to form the uterus and fallopian tubes. AMH production in women begins later, after birth, when it takes on a completely separate job in the ovaries.
How AMH Works in the Ovaries
After birth, AMH is produced by the granulosa cells surrounding small, growing follicles in the ovary.4PubMed. Anti-Müllerian hormone and its role in ovarian function Think of it as a braking mechanism on the ovary’s egg supply. A woman is born with a fixed pool of primordial follicles, each containing an immature egg. Throughout life, small batches of these dormant follicles “wake up” and begin growing. AMH puts the brakes on two stages of that process: it slows the initial activation of dormant follicles, and it reduces how sensitive growing follicles are to follicle-stimulating hormone (FSH), the pituitary signal that drives follicle maturation.5PubMed. Anti-Müllerian hormone and its role in ovarian function
Research on the molecular level has shown that AMH helps keep primordial follicles dormant through specific signaling pathways that prevent premature depletion of the ovarian pool.6PubMed Central. The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle reserve during chemotherapy In practical terms, AMH is the ovary’s way of protecting its egg supply, ensuring that not too many follicles develop at once and the reserve lasts across reproductive years. When AMH decreases as a follicle grows, that brake is released, allowing the follicle to become more responsive to FSH and potentially proceed toward ovulation.7PubMed. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells
Why Fertility Clinics Measure AMH
Because AMH is produced by small growing follicles, the amount circulating in a woman’s blood closely reflects how many of those follicles she has at any given time. That makes it a useful proxy for ovarian reserve.8PubMed Central. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function Compared with other markers like FSH or the ultrasound-based antral follicle count, AMH correlates more tightly with the number of early antral follicles.9PubMed Central. The correlation of the antral follicle count and Serum anti-mullerian hormone
AMH has a practical advantage over FSH: it can be drawn on any day of the menstrual cycle. FSH fluctuates significantly throughout the cycle, so it has to be measured on specific days to be interpretable. AMH stays relatively stable from cycle to cycle, making it far more convenient for both patients and clinicians.
The place where AMH measurement matters most is in IVF planning. One study found that the number of eggs retrieved during an IVF cycle was strongly correlated with the patient’s AMH level, more so than with FSH.10PubMed Central. Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes Clinicians use AMH to anticipate whether a woman will respond poorly to ovarian stimulation (producing very few eggs) or overly strongly (risking complications like ovarian hyperstimulation syndrome). A systematic review and meta-analysis comparing AMH with antral follicle count found that both tests perform similarly in predicting poor or high ovarian response, with neither having a clear overall advantage.11PubMed Central. Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis An earlier meta-analysis reached the same conclusion, confirming that AMH has at least the same accuracy and clinical value as the antral follicle count for predicting poor response.12PubMed. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count
The Biggest Misconception About Low AMH
Here is where the popular understanding falls apart. Many women who get a low AMH result believe it means they cannot get pregnant naturally. That is not what the evidence shows. A systematic review and meta-analysis looking specifically at whether AMH predicts natural conception found that it has poor predictive value for spontaneous pregnancy, and that low AMH is not associated with reduced natural fertility.13PubMed Central. The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis This held true across both younger and older age groups.
AMH tells you how many eggs are in the reserve, not how good those eggs are. Egg quality, which matters most for natural conception, is driven primarily by age. A 30-year-old with low AMH still has eggs of 30-year-old quality. She may produce fewer eggs in an IVF cycle, which is why AMH matters in that context, but her chances of conceiving on her own in any given month are not meaningfully reduced by a low number alone. The conflation of “ovarian reserve” with “fertility” is one of the most consequential misunderstandings in reproductive medicine, and the rise of direct-to-consumer AMH testing has amplified it.
How AMH Changes Over a Lifetime
AMH levels are not static. In women, they rise during childhood, peak somewhere in the mid-twenties, and then decline gradually through the thirties. After about 40, the decline accelerates.14PubMed Central. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline The rate of decline is not uniform across women, though. A large population-based study found that AMH levels remained consistent along individual trajectories over time, meaning each woman has her own curve, but the shape of that curve varies between individuals.15PubMed Central. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline By the time a woman reaches menopause, AMH is essentially undetectable.
This trajectory is why AMH can sometimes help predict premature ovarian insufficiency (POI), a condition where the ovaries lose their function before age 40. A large retrospective study found that AMH below about 0.5 ng/mL was a strong predictor of POI, with AMH outperforming other hormonal markers for diagnostic accuracy.16PubMed Central. Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study Low AMH in young women can flag a greater risk of the condition and may help catch it earlier.17PubMed. Can we predict menopause and premature ovarian insufficiency?
AMH and Polycystic Ovary Syndrome
While low AMH raises concern in some contexts, unusually high AMH is itself a clinical signal. Women with polycystic ovary syndrome (PCOS) tend to have elevated AMH levels, sometimes two to three times higher than expected for their age. This happens because PCOS involves a large number of small antral follicles, and each one produces AMH. On top of that, each individual follicle in a woman with PCOS appears to produce more AMH than normal.18PubMed. Anti-Müllerian hormone and polycystic ovary syndrome
This excess AMH is not just a bystander. It appears to be part of the problem. High AMH inhibits aromatase activity, an enzyme that converts androgens to estrogen, and reduces the follicle’s ability to respond to FSH. The result is that follicles stall mid-development instead of maturing and releasing an egg, which is the hallmark follicular arrest of PCOS.19Middle East Fertility Society Journal. Role of anti-Mullerian hormone in polycystic ovary syndrome Because elevated AMH correlates so well with PCOS features like androgen excess and irregular periods, some researchers have proposed using it as a diagnostic criterion for the syndrome, potentially replacing the pelvic ultrasound that is currently part of standard diagnosis.20PubMed Central. The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
AMH Also Acts on the Brain
One of the more surprising recent discoveries is that AMH does not limit its work to the gonads. It also acts directly on the brain. Researchers have found that a significant proportion of GnRH neurons, the nerve cells in the hypothalamus that control reproductive hormones, carry receptors for AMH. When AMH binds to these neurons, it increases their firing rate and boosts secretion of GnRH, which in turn drives pulses of luteinizing hormone (LH) from the pituitary.21PubMed Central. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
Further work has shown that AMH can cause structural changes in the hypothalamus, specifically in specialized glial cells called tanycytes. AMH causes these cells to retract their processes, which creates a physical opening that allows more GnRH nerve terminals to reach nearby blood vessels. In normal physiology, this ramp-up in GnRH access to the bloodstream appears to play a role in the surge that triggers ovulation. But in PCOS, where AMH is chronically elevated, this mechanism may be stuck in overdrive, contributing to the hormone imbalances that characterize the condition.22PubMed Central. Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome
What Affects Your AMH Level Besides Age
Several lifestyle and medical factors can shift AMH readings, sometimes substantially. A large study tracking women over time found that oral contraceptive use was associated with roughly 40% lower AMH levels compared with women who had never used them. Interestingly, those same users also showed a slower rate of AMH decline, suggesting the pill may suppress the signal without accelerating actual egg loss.23Reproductive BioMedicine Online. Exploring the association between lifestyle factors and anti-Müllerian hormone concentration and rate of decline This is clinically important: a woman tested while on the pill could get a misleadingly low result.
Smoking also lowers AMH. Current smokers had about 20% lower levels and former smokers about 13% lower, though smoking did not change the rate at which AMH declined over time.24Reproductive BioMedicine Online. Exploring the association between lifestyle factors and anti-Müllerian hormone concentration and rate of decline High coffee and tea intake was linked to about 10% higher AMH. Body mass index, waist-to-hip ratio, physical exercise, and alcohol consumption did not show significant associations after accounting for other factors.25Reproductive BioMedicine Online. Exploring the association between lifestyle factors and anti-Müllerian hormone concentration and rate of decline
Vitamin D supplementation has a curious split effect. In women with PCOS, supplementation was associated with a decrease in AMH, which may actually be beneficial since those women start with excess. In ovulatory women without PCOS, vitamin D supplementation was associated with an increase in AMH.26PubMed Central. The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis The mechanism behind this bidirectional effect remains unclear.
The Problem With AMH Tests
Despite how widely AMH is measured, the tests themselves have a significant and underappreciated problem: they are not standardized. Different assay platforms, using different antibodies, can give meaningfully different results from the same blood sample.27PubMed Central. Variation in the Measurement of Anti-Müllerian Hormone – What Are the Laboratory Issues? This has been an ongoing issue since the early days of AMH testing, when European and American assays used entirely different antibodies and reported results in different units.28American Journal of Obstetrics and Gynecology. Contemporary ovarian reserve tests
Efforts to create an international reference standard are underway, but the technical obstacles are real. An international study of a candidate reference preparation found that the variation across assay methods was nearly 40%, and even among commercially available assays the variation was about 27%.29PubMed Central. Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone What this means for you is that an AMH result from one lab may not be directly comparable to a result from another lab, and that rigid cutoff values should be interpreted with caution. If you are tracking AMH over time, getting your tests done at the same lab with the same platform is the most reliable approach.
AMH in Male and Pediatric Medicine
While the conversation around AMH is dominated by female fertility, the hormone plays clinically important roles in males too. In boys, AMH is produced by Sertoli cells in the testes and is detectable at high levels during childhood, declining as puberty begins and testosterone rises. One of the most valuable pediatric uses is in evaluating cryptorchidism, the condition where one or both testicles fail to descend. A detectable AMH level in a boy with non-palpable testes suggests that functional testicular tissue exists somewhere in the body; an undetectable AMH strongly suggests the testes are absent. In children with cryptorchidism and no ambiguous genitalia, AMH had about 98% sensitivity and 91% specificity for identifying the presence of testicular tissue.30PubMed Central. Clinical Utility of Anti-Mullerian Hormone in Pediatrics That level of accuracy can spare a child an unnecessary surgical exploration.
Cryptorchid boys as a group tend to have lower AMH levels than those with normally descended testes, suggesting that the condition reflects broader testicular function issues, not just a positioning problem.31PubMed Central. Anti-Müllerian Hormone and Testicular Function in Prepubertal Boys With Cryptorchidism
There is also a rare condition called persistent Müllerian duct syndrome, where boys are born with a uterus and fallopian tubes despite being genetically male with normal external genitalia. This happens because of mutations either in the AMH gene itself or in the gene for its receptor. Measuring serum AMH helps clinicians distinguish between the two causes: if AMH is very low or undetectable, the problem is usually in the hormone’s production; if AMH is normal, the receptor is the more likely culprit.32PubMed. A novel mutation of anti-Mullerian hormone gene in Persistent Mullerian Duct Syndrome presented with bilateral cryptorchidism: a case report Genetic studies of affected families have confirmed mutations in both the AMH gene and its receptor gene as causes.33PubMed. Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families
AMH as a Tumor Marker
Granulosa cell tumors of the ovary are uncommon, but they produce AMH, which makes the hormone useful both for diagnosis and for catching recurrences. A meta-analysis found that AMH had about 89% sensitivity and 93% specificity for detecting these tumors.34PubMed. Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis Earlier comparative work established that AMH is a sensitive and reliable marker for adult-type granulosa cell tumors and is useful for monitoring treatment response and detecting recurrence early.35PubMed. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol Because these tumors can recur years after initial treatment, having a reliable blood marker is particularly valuable for long-term surveillance.
Protecting Eggs During Chemotherapy
Since AMH naturally keeps primordial follicles dormant, researchers have wondered whether giving extra AMH during chemotherapy could protect the egg supply from being destroyed. Chemotherapy drugs tend to “wake up” dormant follicles, accelerating their depletion and sometimes pushing young women into early menopause. Recombinant AMH delivered alongside chemotherapy might counteract that by maintaining follicle dormancy.36PubMed Central. Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications Animal studies have shown promising results, with AMH and other compounds appearing to protect the ovarian reserve against chemotherapy-induced damage in mouse models.37PubMed. Temsirolimus and antimüllerian hormone protect fertility and the ovarian reserve against chemotherapy-induced damage in a murine model This is still in early-stage research and not yet available as a clinical treatment, but it represents one of the more exciting potential therapeutic uses of the hormone itself rather than just its measurement.
AMH During Testosterone Therapy
For transgender men and other individuals assigned female at birth who take testosterone, a common concern is whether hormone therapy depletes the ovarian reserve. The evidence so far is reassuring. Research has found that AMH levels decrease slightly during testosterone treatment but remain within the normal range, suggesting that the follicular ovarian reserve is broadly preserved.38PubMed. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment Histological examination of ovarian tissue from individuals who had undergone surgery after testosterone therapy showed that the vast majority of follicles were in the primordial (dormant) stage, with antral follicles still visible on ultrasound in over 90% of cases.39PubMed. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy These findings are relevant for individuals who may want to pursue fertility options in the future.
AMH Across Species
AMH is not unique to mammals. The gene is ancient and plays roles in sex differentiation across vertebrates, though the details vary. In birds, AMH is involved in the regression of the right oviduct in females, a quirk of avian anatomy where only the left reproductive tract fully develops.40PubMed. Expression and regulation of anti-mullerian hormone in an oviparous species, the hen Unlike in mammals, where AMH expression is limited to the male gonad during embryonic development, birds express AMH in both male and female fetal gonads. Reptiles share this feature, and in both groups the regulatory sequences controlling AMH expression differ from those in mammals.41PubMed. Subcellular and molecular mechanisms regulating anti-Müllerian hormone gene expression in mammalian and nonmammalian species The conservation of this hormone across such diverse animals underscores just how fundamental the Müllerian duct regression mechanism is in vertebrate reproductive biology, even as evolution has repurposed the hormone’s timing and tissue-specific expression in different lineages.